{"id":6664,"date":"2020-05-06T15:27:05","date_gmt":"2020-05-06T22:27:05","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=6664"},"modified":"2021-03-16T15:27:59","modified_gmt":"2021-03-16T22:27:59","slug":"clinical-characteristics-and-outcomes-of-cancer-patients-with-covid%e2%80%9019","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/05\/06\/clinical-characteristics-and-outcomes-of-cancer-patients-with-covid%e2%80%9019\/","title":{"rendered":"Clinical characteristics and outcomes of cancer patients with COVID\u201019"},"content":{"rendered":"<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"34\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">This retrospective study summarized clinical characteristics and outcomes of 52 cancer patients with COVID-19. Results show that the infection rate of SARS-COV-2 in cancer patients was higher than the general population. Lymphocyte<\/span><span data-contrast=\"auto\">\u00a0levels\u00a0<\/span><span data-contrast=\"auto\">were\u00a0<\/span><span data-contrast=\"auto\">lower\u00a0<\/span><span data-contrast=\"auto\">among patients with\u00a0<\/span><span data-contrast=\"auto\">mild\u00a0<\/span><span data-contrast=\"auto\">COVID-19 disease compared to<\/span><span data-contrast=\"auto\">\u00a0severe\/critical patients. D-dimer, C-reactive protein, procalcitonin<\/span><span data-contrast=\"auto\">,<\/span><span data-contrast=\"auto\">\u00a0lactate dehydrogenase\u00a0<\/span><span data-contrast=\"auto\">and i<\/span><span data-contrast=\"auto\">nterleukin-6\u00a0<\/span><span data-contrast=\"auto\">were\u00a0<\/span><span data-contrast=\"auto\">significantly\u00a0<\/span><span data-contrast=\"auto\">higher\u00a0<\/span><span data-contrast=\"auto\">in severe\/critical patients compared to mild patients. Cancer patients with COVID-19 showed deteriorating conditions and poor outcomes<\/span><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><i><span data-contrast=\"none\">Yang et al. (May 5, 2020). Clinical characteristics and outcomes of cancer patients with COVID\u201019.\u00a0<\/span><\/i><i><span data-contrast=\"none\">Journal of Medical Virology<\/span><\/i><i><span data-contrast=\"none\">.<\/span><\/i><i><span data-contrast=\"none\">\u00a0<\/span><\/i><a href=\"https:\/\/doi.org\/10.1002\/jmv.25972\"><span data-contrast=\"none\">https:\/\/doi.org\/10.1002\/jmv.25972<\/span><\/a><i><span data-contrast=\"none\">\u00a0<\/span><\/i><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559685&quot;:720,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>This retrospective study summarized clinical characteristics and outcomes of 52 cancer patients with COVID-19. Results show that the infection rate of SARS-COV-2 in cancer patients was higher than the general population. Lymphocyte\u00a0levels\u00a0were\u00a0lower\u00a0among patients with\u00a0mild\u00a0COVID-19 disease compared to\u00a0severe\/critical patients. D-dimer, C-reactive protein, procalcitonin,\u00a0lactate dehydrogenase\u00a0and interleukin-6\u00a0were\u00a0significantly\u00a0higher\u00a0in severe\/critical patients compared to mild patients. Cancer patients with COVID-19 showed&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/05\/06\/clinical-characteristics-and-outcomes-of-cancer-patients-with-covid%e2%80%9019\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[],"topic":[20],"class_list":["post-6664","post","type-post","status-publish","format-standard","hentry","category-article-summary","topic-clinical-characteristics-and-health-care-setting"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/6664","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=6664"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/6664\/revisions"}],"predecessor-version":[{"id":6665,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/6664\/revisions\/6665"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=6664"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=6664"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=6664"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=6664"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}